Skip to main content
. 2020 May 5;9(5):232. doi: 10.3390/antibiotics9050232

Figure 1.

Figure 1

PET-CT scans of Patient 3 before (A) and seven months after (B) phage therapy in the area of the aortic graft and of Patient 4 before (C) and two months after (D) phage therapy in the area of the left ventricular assist device (LVAD) and pleural cavity empyema. Yellow emission shows level of accumulation of the tracer substance (2-[18F]fluoro-2-desoxy-D-glucose), which corresponds to inflammation.